Skip to main content

Peer Review reports

From: Effect of KRAS codon13 mutations in patients with advanced colorectal cancer (advanced CRC) under oxaliplatin containing chemotherapy. Results from a translational study of the AIO colorectal study group

Original Submission
18 Sep 2011 Submitted Original manuscript
16 Oct 2011 Reviewed Reviewer Report - Susan Richman
2 Nov 2011 Reviewed Reviewer Report - Frederic Bibeau
4 Nov 2011 Reviewed Reviewer Report - katia bencardino
25 Feb 2012 Author responded Author comments - Anke Reinacher-Schick
Resubmission - Version 2
25 Feb 2012 Submitted Manuscript version 2
6 Mar 2012 Reviewed Reviewer Report - Susan Richman
13 Mar 2012 Reviewed Reviewer Report - katia bencardino
11 Apr 2012 Reviewed Reviewer Report - Frederic Bibeau
23 Apr 2012 Author responded Author comments - Anke Reinacher-Schick
Resubmission - Version 3
23 Apr 2012 Submitted Manuscript version 3
8 May 2012 Reviewed Reviewer Report - Susan Richman
15 Jun 2012 Author responded Author comments - Anke Reinacher-Schick
Resubmission - Version 4
15 Jun 2012 Submitted Manuscript version 4
Publishing
26 Jun 2012 Editorially accepted
9 Aug 2012 Article published 10.1186/1471-2407-12-349

You can find further information about peer review here.

Back to article page